A Dynamical Framework for the All-or-None G1/S Transition

Cell Systems

Volumn 2, Issue 1, 2016, Pages 27-37

  Barr, Alexis R ^a   Heldt, Frank S ^b   Zhang, Tongli ^b   Bakal, Chris ^a   Novák, Béla ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; DNA; SMALL INTERFERING RNA; ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LYSATE; CONTROLLED STUDY; DNA REPLICATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GENE SWITCHING; HELA CELL LINE; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; STOCHASTIC MODEL; UBIQUITINATION; CELL CYCLE CHECKPOINT; CELL CYCLE G1 PHASE;

ANAPHASE-PROMOTING COMPLEX-CYCLOSOME; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; G1 PHASE; HUMANS; S PHASE;

EID: 84958236911     PISSN: 24054712     EISSN: 24054720     Source Type: Journal    
DOI: 10.1016/j.cels.2016.01.001     Document Type: Article

References (73)

1. U. Asghar, A.K. Witkiewicz, N.C. Turner, and E.S. Knudsen The history and future of targeting cyclin-dependent kinases in cancer therapy Nat. Rev. Drug Discov. 14 2015 130 146
2. T. Bashir, N.V. Dorrello, V. Amador, D. Guardavaccaro, and M. Pagano Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase Nature 428 2004 190 193
3. C. Bertoli, J.M. Skotheim, and R.A. de Bruin Control of cell cycle transcription during G1 and S phases Nat. Rev. Mol. Cell Biol. 14 2013 518 528
4. M. Boshart, L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer EMBO J. 3 1984 1151 1157
5. K. Butz, L. Shahabeddin, C. Geisen, D. Spitkovsky, A. Ullmann, and F. Hoppe-Seyler Functional p53 protein in human papillomavirus-positive cancer cells Oncogene 10 1995 927 936
6. A.C. Carrano, E. Eytan, A. Hershko, and M. Pagano SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat. Cell Biol. 1 1999 193 199
7. G. Charvin, C. Oikonomou, E.D. Siggia, and F.R. Cross Origin of irreversibility of cell cycle start in budding yeast PLoS Biol. 8 2010 e1000284
8. K.C. Chen, A. Csikasz-Nagy, B. Gyorffy, J. Val, B. Novak, and J.J. Tyson Kinetic analysis of a molecular model of the budding yeast cell cycle Mol. Biol. Cell 11 2000 369 391
9. I.M. Chu, L. Hengst, and J.M. Slingerland The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy Nat. Rev. Cancer 8 2008 253 267
10. G. Ciotta, H. Hofemeister, M. Maresca, J. Fu, M. Sarov, K. Anastassiadis, and A.F. Stewart Recombineering BAC transgenes for protein tagging Methods 53 2011 113 119
11. F.R. Cross, V. Archambault, M. Miller, and M. Klovstad Testing a mathematical model of the yeast cell cycle Mol. Biol. Cell 13 2002 52 70
12. F.R. Cross, N.E. Buchler, and J.M. Skotheim Evolution of networks and sequences in eukaryotic cell cycle control Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 2011 3532 3544
13. N. den Elzen, and J. Pines Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase J. Cell Biol. 153 2001 121 136
14. B. Di Fiore, and J. Pines Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C J. Cell Biol. 177 2007 425 437
15. V. Dulić, E. Lees, and S.I. Reed Association of human cyclin E with a periodic G1-S phase protein kinase Science 257 1992 1958 1961
16. M. Dürst, C.M. Croce, L. Gissmann, E. Schwarz, and K. Huebner Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas Proc. Natl. Acad. Sci. USA 84 1987 1070 1074
17. J. Essers, A.F. Theil, C. Baldeyron, W.A. van Cappellen, A.B. Houtsmuller, R. Kanaar, and W. Vermeulen Nuclear dynamics of PCNA in DNA replication and repair Mol. Cell. Biol. 25 2005 9350 9359
18. M.L. Fero, M. Rivkin, M. Tasch, P. Porter, C.E. Carow, E. Firpo, K. Polyak, L.H. Tsai, V. Broudy, R.M. Perlmutter, and et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice Cell 85 1996 733 744
19. S. Geley, E. Kramer, C. Gieffers, J. Gannon, J.M. Peters, and T. Hunt Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint J. Cell Biol. 153 2001 137 148
20. Y. Geng, E.N. Eaton, M. Picón, J.M. Roberts, A.S. Lundberg, A. Gifford, C. Sardet, and R.A. Weinberg Regulation of cyclin E transcription by E2Fs and retinoblastoma protein Oncogene 12 1996 1173 1180
21. Y. Geng, Q. Yu, E. Sicinska, M. Das, J.E. Schneider, S. Bhattacharya, W.M. Rideout, R.T. Bronson, H. Gardner, and P. Sicinski Cyclin E ablation in the mouse Cell 114 2003 431 443
22. J. Gu, X. Xia, P. Yan, H. Liu, V.N. Podust, A.B. Reynolds, and E. Fanning Cell cycle-dependent regulation of a human DNA helicase that localizes in DNA damage foci Mol. Biol. Cell 15 2004 3320 3332
23. M. Held, M.H. Schmitz, B. Fischer, T. Walter, B. Neumann, M.H. Olma, M. Peter, J. Ellenberg, and D.W. Gerlich CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging Nat. Methods 7 2010 747 754
24. D.D. Hershko Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target Future Oncol. 6 2010 1837 1847
25. J.Y. Hsu, J.D. Reimann, C.S. Sørensen, J. Lukas, and P.K. Jackson E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1) Nat. Cell Biol. 4 2002 358 366
26. J.R. Hutchins, Y. Toyoda, B. Hegemann, I. Poser, J.K. Hériché, M.M. Sykora, M. Augsburg, O. Hudecz, B.A. Buschhorn, J. Bulkescher, and et al. Systematic analysis of human protein complexes identifies chromosome segregation proteins Science 328 2010 593 599
27. A. Johnson, and J.M. Skotheim Start and the restriction point Curr. Opin. Cell Biol. 25 2013 717 723
28. J.M. Keck, M.K. Summers, D. Tedesco, S. Ekholm-Reed, L.C. Chuang, P.K. Jackson, and S.I. Reed Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1) J. Cell Biol. 178 2007 371 385
29. H. Kiyokawa, R.D. Kineman, K.O. Manova-Todorova, V.C. Soares, E.S. Hoffman, M. Ono, D. Khanam, A.C. Hayday, L.A. Frohman, and A. Koff Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) Cell 85 1996 721 732
30. A. Koff, A. Giordano, D. Desai, K. Yamashita, J.W. Harper, S. Elledge, T. Nishimoto, D.O. Morgan, B.R. Franza, and J.M. Roberts Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle Science 257 1992 1689 1694
31. K.W. Kohn Molecular interaction map of the mammalian cell cycle control and DNA repair systems Mol. Biol. Cell 10 1999 2703 2734
32. M. Kõivomägi, E. Valk, R. Venta, A. Iofik, M. Lepiku, E.R. Balog, S.M. Rubin, D.O. Morgan, and M. Loog Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase Nature 480 2011 128 131
33. P.A. Lazo, J.A. DiPaolo, and N.C. Popescu Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′-flanking cellular sequence located near the myc protooncogene in HeLa cells Cancer Res. 49 1989 4305 4310
34. H. Leonhardt, H.P. Rahn, P. Weinzierl, A. Sporbert, T. Cremer, D. Zink, and M.C. Cardoso Dynamics of DNA replication factories in living cells J. Cell Biol. 149 2000 271 280
35. C. Lukas, C.S. Sørensen, E. Kramer, E. Santoni-Rugiu, C. Lindeneg, J.M. Peters, J. Bartek, and J. Lukas Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex Nature 401 1999 815 818
36. Y.J. Machida, and A. Dutta The APC/C inhibitor, Emi1, is essential for prevention of rereplication Genes Dev. 21 2007 184 194
37. A. Martín, J. Odajima, S.L. Hunt, P. Dubus, S. Ortega, M. Malumbres, and M. Barbacid Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1) Cancer Cell 7 2005 591 598
38. J.J. Miller, M.K. Summers, D.V. Hansen, M.V. Nachury, N.L. Lehman, A. Loktev, and P.K. Jackson Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor Genes Dev. 20 2006 2410 2420
39. A. Montagnoli, F. Fiore, E. Eytan, A.C. Carrano, G.F. Draetta, A. Hershko, and M. Pagano Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation Genes Dev. 13 1999 1181 1189
40. C.A. Moody, and L.A. Laimins Human papillomavirus oncoproteins: pathways to transformation Nat. Rev. Cancer 10 2010 550 560
41. D.O. Morgan Cyclin-dependent kinases: engines, clocks, and microprocessors Annu. Rev. Cell Dev. Biol. 13 1997 261 291
42. D. Müller, C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes Oncogene 15 1997 2561 2576
43. K. Nakayama, N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D.Y. Loh, and K. Nakayama Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
44. P. Nash, X. Tang, S. Orlicky, Q. Chen, F.B. Gertler, M.D. Mendenhall, F. Sicheri, T. Pawson, and M. Tyers Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication Nature 414 2001 514 521
45. K.J. Neelsen, I.M. Zanini, S. Mijic, R. Herrador, R. Zellweger, A. Ray Chaudhuri, K.D. Creavin, J.J. Blow, and M. Lopes Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template Genes Dev. 27 2013 2537 2542
46. K. Ohtani, J. DeGregori, and J.R. Nevins Regulation of the cyclin E gene by transcription factor E2F1 Proc. Natl. Acad. Sci. USA 92 1995 12146 12150
47. K.W. Overton, S.L. Spencer, W.L. Noderer, T. Meyer, and C.L. Wang Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states Proc. Natl. Acad. Sci. USA 111 2014 E4386 E4393
48. K.D. Piatkevich, J. Hulit, O.M. Subach, B. Wu, A. Abdulla, J.E. Segall, and V.V. Verkhusha Monomeric red fluorescent proteins with a large Stokes shift Proc. Natl. Acad. Sci. USA 107 2010 5369 5374
49. J. Pines, and T. Hunter Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B Nature 346 1990 760 763
50. J.R. Pomerening, J.A. Ubersax, and J.E. Ferrell Jr. Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF Mol. Biol. Cell 19 2008 3426 3441
51. I. Poser, M. Sarov, J.R. Hutchins, J.K. Hériché, Y. Toyoda, A. Pozniakovsky, D. Weigl, A. Nitzsche, B. Hegemann, A.W. Bird, and et al. BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals Nat. Methods 5 2008 409 415
52. A. Sabile, A.M. Meyer, C. Wirbelauer, D. Hess, U. Kogel, M. Scheffner, and W. Krek Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein Mol. Cell. Biol. 26 2006 5994 6004
53. M. Scaltriti, P.J. Eichhorn, J. Cortés, L. Prudkin, C. Aura, J. Jiménez, S. Chandarlapaty, V. Serra, A. Prat, Y.H. Ibrahim, and et al. Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients Proc. Natl. Acad. Sci. USA 108 2011 3761 3766
54. B. Schwanhäusser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf, W. Chen, and M. Selbach Global quantification of mammalian gene expression control Nature 473 2011 337 342
55. E. Schwarz, U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen Structure and transcription of human papillomavirus sequences in cervical carcinoma cells Nature 314 1985 111 114
56. E. Schwob, T. Böhm, M.D. Mendenhall, and K. Nasmyth The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae Cell 79 1994 233 244
57. R.J. Sheaff, M. Groudine, M. Gordon, J.M. Roberts, and B.E. Clurman Cyclin E-CDK2 is a regulator of p27Kip1 Genes Dev. 11 1997 1464 1478
58. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
59. J.M. Skotheim, S. Di Talia, E.D. Siggia, and F.R. Cross Positive feedback of G1 cyclins ensures coherent cell cycle entry Nature 454 2008 291 296
60. C.S. Sørensen, C. Lukas, E.R. Kramer, J.M. Peters, J. Bartek, and J. Lukas A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression Mol. Cell. Biol. 21 2001 3692 3703
61. S.L. Spencer, S.D. Cappell, F.C. Tsai, K.W. Overton, C.L. Wang, and T. Meyer The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit Cell 155 2013 369 383
62. O. Tetsu, and F. McCormick Proliferation of cancer cells despite CDK2 inhibition Cancer Cell 3 2003 233 245
63. S. van den Heuvel, and E. Harlow Distinct roles for cyclin-dependent kinases in cell cycle control Science 262 1993 2050 2054
64. A. Verdugo, P.K. Vinod, J.J. Tyson, and B. Novak Molecular mechanisms creating bistable switches at cell cycle transitions Open Biol. 3 2013 120179
65. J. Vlach, S. Hennecke, and B. Amati Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27 EMBO J. 16 1997 5334 5344
66. W. Wei, N.G. Ayad, Y. Wan, G.J. Zhang, M.W. Kirschner, and W.G. Kaelin Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex Nature 428 2004 194 198
67. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
68. K.A. Won, and S.I. Reed Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E EMBO J. 15 1996 4182 4193
69. X. Yang, K.Y. Lau, V. Sevim, and C. Tang Design principles of the yeast G1/S switch PLoS Biol. 11 2013 e1001673
70. G. Yao, T.J. Lee, S. Mori, J.R. Nevins, and L. You A bistable Rb-E2F switch underlies the restriction point Nat. Cell Biol. 10 2008 476 482
71. X. Yuan, J. Srividhya, T. De Luca, J.H. Lee, and J.R. Pomerening Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset Mol. Biol. Cell 25 2014 441 456
72. W. Zachariae, M. Schwab, K. Nasmyth, and W. Seufert Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex Science 282 1998 1721 1724
73. A. Zetterberg, O. Larsson, and K.G. Wiman What is the restriction point? Curr. Opin. Cell Biol. 7 1995 835 842